Navigation Links
Research Reveals Functions Of Harmful Shellfish Pathogens

Providing safer shellfish is the goal of Agricultural Research Service (ARS) scientists who are studying the means by which pathogenic bacteria enter shellfish.

In the United States, two pathogenic bacteria from the genus Vibrio are of concern: V. vulnificus and V. parahaemolyticus. These bacteria are naturally found in shellfish and seawater, particularly when water temperatures are warm, and can lead to serious health concerns.

ARS scientists at the Microbial Safety of Aquaculture Products Center of Excellence in Dover, Del., are studying these bacteria with the goal of keeping them out of shellfish. Gary P. Richards, a microbiologist and the center's lead scientist, wants to identify Vibrio enzymes that may help the organism enter shellfish--and, eventually, a human host.

Richards, who leads a group of scientists from Delaware State University and the National Institutes of Health, recently discovered in V. vulnificus an enzyme called phosphoglucose isomerase. This enzyme could provide a way for Vibrio to spread more easily.

He also detected the enzyme in virtually all species of Vibrio tested, but not in non-Vibrio pathogens. The enzyme is capable of producing what are called vasoactive peptides, which could contribute to rapid spread of V. vulnificus in humans. A study of V. vulnificus in oysters suggests that strains virulent to humans may be more invasive to--and persistent in--oysters.

The Dover center, a field location of the ARS Eastern Regional Research Center in Wyndmoor, Pa., also studies methods to detect norovirus and the hepatitis A virus in shellfish. It also develops high-pressure processing techniques to inactivate enteric viruses in contaminated shellfish.

This research may provide better diagnostic capabilities and treatment strategies to further reduce shellfish-related illnesses.

ARS is the U.S. Department of Agriculture's chief scientific research agency.


'"/>

Source:USDA / Agricultural Research Service


Page: 1

Related biology news :

1. Researchers discover way to make cells in the eye sensitive to light
2. Quantum Dots Research Leads to New Knowledge about Protein Binding in Plants
3. Researchers find how protein allows insects to detect and respond to pheromones
4. Researchers Uncover Key Step In Manufacture of Memory Protein
5. Research advances quest for HIV-1 vaccine
6. Research on Worms Yields Clues on Aging
7. Researchers reveal the infectious impact of salmon farms on wild salmon
8. Researchers identify target for cancer drugs
9. Weill Cornell Research Reveals Secrets Of Trafficking Within Cells
10. Researchers discover molecule that causes secondary stroke
11. Researchers find missing genes of ancient organism
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/13/2017)... , Feb. 13, 2017  RSA Conference -- ... platform that is designed to enhance fraud detection ... release in the RSA Fraud & Risk Intelligence ... organizations to leverage additional insights from internal and ... to better protect their customers from targeted cybercrime ...
(Date:2/8/2017)... Inc. (NASDAQ: AWRE ), a leading supplier of ... quarter and year ended December 31, 2016. ... compared to $6.9 million in the same quarter last year. ... million compared to $2.6 million in the fourth quarter of ... $0.5 million, or $0.02 per diluted share, which compares to ...
(Date:2/7/2017)... Ind. , Feb. 7, 2017 Zimmer ... leader in musculoskeletal healthcare, will present at the LEERINK ... New York Palace Hotel on Wednesday, February 15, 2017 ... live webcast of the presentation can be accessed at ... replay following the conference via Zimmer Biomet,s Investor Relations ...
Breaking Biology News(10 mins):
(Date:2/27/2017)... 27, 2017 /PRNewswire/ - InMed Pharmaceuticals, Inc. ("InMed") (CSE: IN; ... Friday, February 24, 2017 a total of 10,672,750 common share ... per common share. Proceeds from the exercise of these warrants ... Treasury.   ... "We are grateful for this expression of confidence by our ...
(Date:2/27/2017)... and HAMILTON, Bermuda ... (NASDAQ: ADXS ) and ... companies focused on developing cancer immunotherapies, today announced ... develop a novel cancer immunotherapy agent using Advaxis, ... SELLAS, patented WT1 targeted heteroclitic peptide antigen mixture ...
(Date:2/27/2017)... ... ... The Catalyst Midwest premix manufacturing facility has been certified as organic, ... label organic services. , The first organic product is Organic 18 Percent Layer Feed, ... Marketing, which owns the facility. , Catalyst already has received the Safe Feed/Safe ...
(Date:2/24/2017)... ... February 24, 2017 , ... ... can be safely completed in an ambulatory surgery center (ASC) with satisfactory clinical ... and previous two-year TDR studies. , Jake Lubinski, president of AxioMed, commented ...
Breaking Biology Technology: